Impacts of neoadjuvant therapy on the number of dissected lymph nodes in esophagogastric junction cancer patients

BACKGROUND: Neoadjuvant therapy favors the prognosis of various cancers, including esophagogastric junction cancer (EGC). However, the impacts of neoadjuvant therapy on the number of dissected lymph nodes (LNs) have not yet been evaluated in EGC. METHODS: We selected EGC patients from the Surveillan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Ge, Jin-tong, Wu, Hua, Zhong, Sheng, Wu, Qing-quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999651/
https://www.ncbi.nlm.nih.gov/pubmed/36894903
http://dx.doi.org/10.1186/s12876-023-02705-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999651/
https://www.ncbi.nlm.nih.gov/pubmed/36894903
http://dx.doi.org/10.1186/s12876-023-02705-7

Ejemplares similares